LUNG THERAPEUTICS, INC. sold 26.3% of their position (1.05M shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $14.55M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/8/2020ACC: 0001213900-20-041606
10% Owner
Since Oct 2019
-1.05M
Net shares
Net seller
$14.55M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.05M disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−500K
Price / share
$13.85
Trade value
$6.92M
% of position
12.5%
12/4/2020
4M→3.50M
Common Stock
Direct
Shares
−300K
Price / share
$13.86
Trade value
$4.16M
% of position
8.6%
12/4/2020
3.50M→3.20M
Common Stock
Direct
Shares
−250K
Price / share
$13.86
Trade value
$3.46M
% of position
7.8%
12/4/2020
3.20M→2.95M
Total
Net shares
−1.05M
Net value
-$14.55M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2020 | S · Sale | −500K | $13.85 | $6.92M | 12.5% | 4M | 3.50M |
| Common Stock Direct | 12/4/2020 | S · Sale | −300K | $13.86 | $4.16M | 8.6% | 3.50M | 3.20M |
| Common Stock Direct | 12/4/2020 | S · Sale | −250K | $13.86 | $3.46M | 7.8% | 3.20M | 2.95M |
| Total | −1.05M | -$14.55M | ||||||
Derivative Transactions0
No derivative transactions reported